A multicenter paper-based and web-based system for collecting patient-reported outcome measures in patients undergoing local treatment for prostate cancer: first experiences.

Certification Functional status Health services research Implementation Improvement intervention Multidisciplinary studies Patient-reported outcomes Prostate cancer

Journal

Journal of patient-reported outcomes
ISSN: 2509-8020
Titre abrégé: J Patient Rep Outcomes
Pays: Germany
ID NLM: 101722688

Informations de publication

Date de publication:
13 Jul 2020
Historique:
received: 02 01 2020
accepted: 28 06 2020
entrez: 15 7 2020
pubmed: 15 7 2020
medline: 15 7 2020
Statut: epublish

Résumé

To give an overview of the multicenter Prostate Cancer Outcomes (PCO) study, involving paper-based and web-based collection of patient-reported outcome measures (PROM) in patients undergoing local treatment for prostate cancer in certified centers in Germany. The PCO study is part of the larger Movember-funded TrueNTH Global Registry. The article reports on the study's design and provides a brief progress report after the first 2 years of data collection. Prostate cancer centers (PCCs) certified according to German Cancer Society requirements were invited to participate in collecting patient-reported information on symptoms and function before and at least once (at 12 months) after treatment. The data were matched with disease and treatment information. This report describes progress in patient inclusion, response rate, and variations between centers relative to online/paper use, and also data quality, including recruitment variations relative to treatment in the first participating PCCs. PCC participation increased over time; 44 centers had transferred data for 3094 patients at the time of this report. Patient recruitment varied widely across centers. Recruitment was highest among patients undergoing radical prostatectomy. The completeness of the data was good, except for comorbidity information. The PCO study benefits from a quality improvement system first established over 10 years ago, requiring collection and harmonization of a predefined clinical dataset across centers. Nevertheless, establishing a PROM routine requires substantial effort on the part of providers and constant monitoring in order to achieve high-quality data. The findings reported here may be useful for guiding implementation in similar initiatives.

Identifiants

pubmed: 32661594
doi: 10.1186/s41687-020-00224-7
pii: 10.1186/s41687-020-00224-7
pmc: PMC7359206
doi:

Types de publication

Journal Article

Langues

eng

Pagination

56

Subventions

Organisme : Movember Foundation
ID : n.a.

Références

World J Urol. 2016 May;34(5):665-72
pubmed: 26391484
BJU Int. 2014 Dec;114(6b):E74-E81
pubmed: 24588845
BMJ Open. 2017 Nov 28;7(11):e017006
pubmed: 29183925
Scand J Urol. 2016 Aug;50(4):280-5
pubmed: 27049891
Urologe A. 2015 Nov;54(11):1591-5
pubmed: 26347350
World J Urol. 2019 Sep 24;:
pubmed: 31552467
Br J Cancer. 2012 Feb 28;106(5):826-38
pubmed: 22315052
J Clin Oncol. 2018 Apr 20;36(12):1192-1198
pubmed: 29489433
Health Qual Life Outcomes. 2010 Sep 21;8:104
pubmed: 20858248
Eur Urol. 2015 Mar;67(3):460-7
pubmed: 25234359
Implement Sci. 2009 May 08;4:25
pubmed: 19426507
Lancet Oncol. 2019 Mar;20(3):436-447
pubmed: 30713036
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28423407
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
JAMA. 2017 Mar 21;317(11):1126-1140
pubmed: 28324093
JAMA. 2017 Jul 11;318(2):197-198
pubmed: 28586821

Auteurs

Christoph Kowalski (C)

German Cancer Society, Kuno-Fischer-Strasse 8, 14057, Berlin, Germany. kowalski@krebsgesellschaft.de.

Rebecca Roth (R)

Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany.

Günther Carl (G)

Help for Prostate Cancer Patients (Förderverein Hilfe bei Prostatakrebs e.V., FHbP), Tornesch, Germany.

Günter Feick (G)

Federal Association of German Prostate Cancer Patient Support Groups, Bonn, Germany.

Alisa Oesterle (A)

OnkoZert, Neu-Ulm, Germany.

Andreas Hinkel (A)

Franziskus Hospital, Bielefeld, Germany.

Thomas Steiner (T)

Helios Klinikum Erfurt, Erfurt, Germany.

Marko Brock (M)

Marien Hospital Herne, Herne, Germany.

Björn Kaftan (B)

Städtisches Klinikum Lüneburg, Lüneburg, Germany.

Rainer Borowitz (R)

Klinikum Memmingen, Memmingen, Germany.

Niko Zantl (N)

Klinikum Singen, Singen, Germany.

Axel Heidenreich (A)

Cologne University Hospital, Cologne, Germany.

Andreas Neisius (A)

Barmherzige Brüder Trier, Trier, Germany.

Christopher Darr (C)

Essen University Hospital, Essen, Germany.

Christian Bolenz (C)

University of Ulm, Ulm, Germany.

Burkhard Beyer (B)

Martini-Klinik Prostate Cancer Center Hamburg, Hamburg, Germany.

Jesco Pfitzenmaier (J)

Evangelisches Klinikum Bethel Johannesstift, Bielefeld, Germany.

Bernhard Brehmer (B)

Diaconal Hospital of Schwäbisch Hall, Schwäbisch Hall, Germany.

Jan Fichtner (J)

Johanniter Krankenhaus Oberhausen, Oberhausen, Germany.

Björn Haben (B)

St. Marien Hospital Ahaus, Ahaus, Germany.

Simone Wesselmann (S)

German Cancer Society, Kuno-Fischer-Strasse 8, 14057, Berlin, Germany.

Sebastian Dieng (S)

OnkoZert, Neu-Ulm, Germany.

Classifications MeSH